bioequivalence
Showing 1 - 25 of 2,708
Bioequivalence Study Trial in Chennai (Pomalidomide 4 MG Oral Capsule)
Not yet recruiting
- Bioequivalence Study
- Pomalidomide 4 MG Oral Capsule
-
Chennai, Tamil Nadu, IndiaAzidus Laboratories
Sep 22, 2023
Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)
Active, not recruiting
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome
-
Haikou, Hainan, ChinaHaikou people's Hospital
Jun 12, 2023
Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)
Not yet recruiting
- Healthy
- Test (T) Bilastine
- Reference (R) Bilastine
- (no location specified)
Oct 19, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023
Myeloma Multiple Trial in Chia (Dasatinib 100 MG)
Not yet recruiting
- Myeloma Multiple
- Dasatinib 100 MG
-
Chia, Cundinamarca, ColombiaCAIMED
Jul 12, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 250/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 1, 2023
Healthy Trial in Cairo (Bravamax 200 mg (Modafinil), Vigil 200 mg (Modafinil))
Completed
- Healthy
- Bravamax 200 mg (Modafinil)
- Vigil 200 mg (Modafinil)
-
Cairo, EgyptGenuine Research Center GRC
May 3, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and
Recruiting
- Bioequivalence
- Schizophrenia
- Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023
Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene
Recruiting
- Bioequivalence Study
- Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
- Calcium Hydroxybenzene Sulfonate Tablets(Doxium®) 250mg
-
Beijing, Beijing, ChinaNational Institue for Drug Clinical Trials
Mar 21, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))
Completed
- Neoplasms
- The test olaparib tablet (T)
- The reference olaparib tablet (R)
-
Bengbu, Anhui, ChinaThe First Affiliated Hospital of Bengbu Medical College
May 15, 2023
Psoriasis and Psoriatic Arthritis Trial in Ahmedabad (Apremilast 30 mg Tablets, Otezla 30 mg film-coated tablets)
Completed
- Psoriasis and Psoriatic Arthritis
- Apremilast 30 mg Tablets
- Otezla 30 mg film-coated tablets
-
Ahmedabad, Gujarat, IndiaLambda Therapeutic Research Ltd.
Oct 18, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
Healthy Volunteers Trial in Seoul (DWJ1558, DWC202310 and DWC202311)
Active, not recruiting
- Healthy Volunteers
- DWJ1558
- DWC202310 and DWC202311
-
Seoul, Korea, Republic ofH Plus YANGJI Hospital
Aug 28, 2023
Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)
Not yet recruiting
- Viral Infection COVID-19
-
Saint Petersburg,, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Oct 23, 2023
Healthy Trial in Cairo (Apipe (Aripiprazole10 mg), Abilify (Aripiprazole10 mg))
Completed
- Healthy
- Apipe (Aripiprazole10 mg)
- Abilify (Aripiprazole10 mg)
-
Cairo, EgyptGenuine Research Center GRC
Mar 27, 2023